FENC Insider Trading Activity and SEC Form 4 Filings
FENC insider trading summary
Over the past 12 months, insiders at Fennec Pharmaceuticals Inc. (FENC) reported 26 sales worth $12.9M by 10 insiders and no open-market purchases on SEC Form 4. Net insider selling was $12.9M.
Latest FENC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Marco Maria Brughera | Insider | Sell | $160K (15,545 @ $10.29) |
| Sep 1, 2026 | Rosty Raykov | Insider | Sell | $121K (10,000 @ $12.11) |
| Aug 31, 2026 | Pierre Sargis Sayad | Chief Medical Officer | Sell | $146K (12,000 @ $12.18) |
| Aug 27, 2026 | Robert Andrade | Chief Financial Officer | Sell | $884K (75,000 @ $11.78) |
| Aug 3, 2026 | Rosty Raykov | Insider | Sell | $96K (10,000 @ $9.58) |
| Jun 1, 2026 | Rosty Raykov | Insider | Sell | $94K (9,747 @ $9.62) |
| May 11, 2026 | Chris A Rallis | Insider | Sell | $59K (8,346 @ $7.04) |
| Apr 1, 2026 | Rosty Raykov | Insider | Sell | $69K (10,946 @ $6.31) |
| Mar 2, 2026 | Rosty Raykov | Insider | Sell | $84K (10,079 @ $8.36) |
| Jan 2, 2026 | Rosty Raykov | Insider | Sell | $78K (10,312 @ $7.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.